Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia.

Mutant isocitrate dehydrogenase (IDH) 1 and 2 proteins alter the epigenetic landscape in acute myeloid leukemia (AML) cells through production of the oncometabolite (R)-2-hydroxyglutarate (2-HG). Here we performed a large-scale RNA interference (RNAi) screen to identify genes that are synthetic lethal to the IDH1(R132H) mutation in AML and identified the anti-apoptotic gene BCL-2. IDH1- and IDH2-mutant primary human AML cells were more sensitive than IDH1/2 wild-type cells to ABT-199, a highly specific BCL-2 inhibitor that is currently in clinical trials for hematologic malignancies, both ex vivo and in xenotransplant models.

Inhibiting platelet-stimulated blood coagulation by inhibition of mitochondrial respiration.

Platelets are important mediators of blood coagulation that lack nuclei, but contain mitochondria. Although the presence of mitochondria in platelets has long been recognized, platelet mitochondrial function remains largely unaddressed. On the basis of a small amount of literature that suggests platelet mitochondria are functional, we hypothesized that the inhibition of platelet mitochondria disrupts platelet function and platelet-activated blood coagulation.

Catalytic Activation of H(2) and C-H Bonds by Electron-Deficient Ruthenium(II) Porphyrins.

The Ru(2) and RuNi derivatives of 1,8-bis(10,15,20-trimesityl-5-porphyrinato)anthracene-a recently reported cofacial diporphyrin ligand comprising two hindered porphyrins spanned by an anthracene bridge-have been synthesized. Both Ru(2)(DPAHM) and RuNi(DPAHM) are extremely reactive species that apparently contain 14-electron Ru(II) centers and, as is the case for their monoporphyrin analog, (5,10,15,20-tetramesitylporphyrinato)ruthenium [Ru(TMP)], must be rigorously protected from oxygen, nitrogen, and other ligating agents. In addition, these electron-deficient Ru(II) porphyrins all appear to bind aromatic solvents such as benzene and toluene, the weakest ligating solvents in which these Ru(II) porphyrins have been found soluble.